Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113457 | Critical Reviews in Oncology/Hematology | 2016 | 12 Pages |
Abstract
MicroRNAs (miRNAs), a highly conserved class of tissue specific, small non-protein coding RNAs maintain cell homeostasis by negative gene regulation. Proper controlling of miRNA expression is required for a balanced physiological environment, as these small molecules influence almost every genetic pathway from cell cycle checkpoint, cell proliferation to apoptosis, with a wide range of target genes. Deregulation in miRNAs expression correlates with various cancers by acting as tumor suppressors and oncogenes. Although promising therapies exist to control tumor development and progression, there is a lack of efficient diagnostic and therapeutic approaches for delineating various types of cancer. The molecularly different tumors can be differentiated by specific miRNA profiling as their phenotypic signatures, which can hence be exploited to surmount the diagnostic and therapeutic challenges. Present review discusses the involvement of miRNAs in oncogenesis with the analysis of patented research available on miRNAs.
Keywords
APCHER-2OncogenesVHLTGFβR2TGF βDAPK1HIFDDXRT-PCRTRBPDEAD box proteinThbs1PSAHSCUSPTONR5A2CeAadenomatous polyposis colialpha-fetoproteincarcinoembryonic antigenProstate specific antigenPatentsOncogeneTransforming growth factor βThrombospondin-1AFPEMTRISCTherapeuticsUnited States Patent and Trademark OfficemicroRNAsReal time-polymerase chain reactionCancerTumor suppressorsTumor suppressorHematopoietic stem cellRNA Induced Silencing ComplexUTR یا untranslated regions untranslated regionMicroRNAMiRNAHuman papilloma virusHPVdeath-associated protein kinase 1epithelial-to-mesenchymal transitionEstrogen receptor
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Shivangi Mishra, Tanuja Yadav, Vibha Rani,